These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19571496)

  • 1. Evaluation of initial diffusion-weighted image findings in acute stroke patients using a semiquantitative score.
    Morita N; Harada M; Uno M; Matsubara S; Nagahiro S; Nishitani H
    Magn Reson Med Sci; 2009; 8(2):47-53. PubMed ID: 19571496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Could clinical diffusion-mismatch determined using DWI ASPECTS predict neurological improvement after thrombolysis before 3 h after acute stroke?
    Terasawa Y; Kimura K; Iguchi Y; Kobayashi K; Aoki J; Shibazaki K; Kaji R
    J Neurol Neurosurg Psychiatry; 2010 Aug; 81(8):864-8. PubMed ID: 20562433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [ASPECTS-DWI, arterial occlusion sites and subtype of acute ischemic stroke have a relation with outcome following intravenous rt-PA therapy].
    Idei M; Sasaki T; Tanabe T; Muraoka K; Terada K; Meguro T; Hirotsune N; Nishino S
    No Shinkei Geka; 2012 Jul; 40(7):585-91. PubMed ID: 22728535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical-diffusion mismatch defined by NIHSS and ASPECTS in non-lacunar anterior circulation infarction.
    Tei H; Uchiyama S; Usui T
    J Neurol; 2007 Mar; 254(3):340-6. PubMed ID: 17345045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified diffusion-weighted imaging-Alberta Stroke Program Early Computed Tomography Score including deep white matter lesions predicts symptomatic intracerebral hemorrhage following intravenous thrombolysis.
    Tanaka K; Matsumoto S; Furuta K; Yamada T; Nagano S; Takase KI; Hatano T; Yamasaki R; Kira JI
    J Thromb Thrombolysis; 2020 Jul; 50(1):174-180. PubMed ID: 31745858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Large ischemic lesions on diffusion-weighted imaging done before intravenous tissue plasminogen activator thrombolysis predicts a poor outcome in patients with acute stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Inoue T; Uemura J; Aoki J
    Stroke; 2008 Aug; 39(8):2388-91. PubMed ID: 18535272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presence of deep white matter lesions on diffusion-weighted imaging is a negative predictor of early dramatic improvement after intravenous tissue plasminogen activator thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    Cerebrovasc Dis; 2010 Aug; 30(3):230-6. PubMed ID: 20606424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baseline magnetic resonance imaging parameters and stroke outcome in patients treated by intravenous tissue plasminogen activator.
    Nighoghossian N; Hermier M; Adeleine P; Derex L; Dugor JF; Philippeau F; Ylmaz H; Honnorat J; Dardel P; Berthezène Y; Froment JC; Trouillas P
    Stroke; 2003 Feb; 34(2):458-63. PubMed ID: 12574560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
    Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
    Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous thrombolysis for patients with reverse magnetic resonance angiography and diffusion-weighted imaging mismatch: SAMURAI and NCVC rt-PA Registries.
    Sakamoto Y; Koga M; Kimura K; Nagatsuka K; Okuda S; Kario K; Hasegawa Y; Okada Y; Yamagami H; Furui E; Nakagawara J; Shiokawa Y; Okata T; Kobayashi J; Tanaka E; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):419-26. PubMed ID: 24261412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining acute diffusion-weighted imaging and mean transmit time lesion volumes with National Institutes of Health Stroke Scale Score improves the prediction of acute stroke outcome.
    Yoo AJ; Barak ER; Copen WA; Kamalian S; Gharai LR; Pervez MA; Schwamm LH; González RG; Schaefer PW
    Stroke; 2010 Aug; 41(8):1728-35. PubMed ID: 20595665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of magnetic resonance angiography-diffusion weighted imaging mismatch in hyperacute cerebral infarction.
    Deguchi I; Takeda H; Furuya D; Dembo T; Nagoya H; Kato Y; Ito Y; Fukuoka T; Maruyama H; Tanahashi N
    J Stroke Cerebrovasc Dis; 2012 Feb; 21(2):108-13. PubMed ID: 20851627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of early neurological deterioration using diffusion- and perfusion-weighted imaging in hyperacute middle cerebral artery ischemic stroke.
    Arenillas JF; Rovira A; Molina CA; Grivé E; Montaner J; Alvarez-Sabín J
    Stroke; 2002 Sep; 33(9):2197-203. PubMed ID: 12215587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and radiological factors associated with unfavorable outcome after intravenous thrombolysis in patients with mild ischemic stroke.
    Kim DH; Lee DS; Nah HW; Cha JK
    BMC Neurol; 2018 Mar; 18(1):30. PubMed ID: 29544461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
    Kruetzelmann A; Köhrmann M; Sobesky J; Cheng B; Rosenkranz M; Röther J; Schellinger PD; Ringleb P; Gerloff C; Fiehler J; Thomalla G
    Stroke; 2011 May; 42(5):1251-4. PubMed ID: 21415399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of hemorrhagic transformation after intravenous recombinant tissue plasminogen activator: prognostic value of the initial apparent diffusion coefficient and diffusion-weighted lesion volume.
    Selim M; Fink JN; Kumar S; Caplan LR; Horkan C; Chen Y; Linfante I; Schlaug G
    Stroke; 2002 Aug; 33(8):2047-52. PubMed ID: 12154261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simple clinical predictors of stroke outcome based on National Institutes of Health Stroke scale score during 1-h recombinant tissue-type plasminogen activator infusion.
    Osaki M; Miyashita F; Koga M; Fukuda M; Shigehatake Y; Nagatsuka K; Minematsu K; Toyoda K
    Eur J Neurol; 2014 Mar; 21(3):411-8. PubMed ID: 24200315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperacute-phase computed tomography-diffusion-weighted imaging discrepancy and response to thrombolysis.
    Kawano H; Hirano T; Inatomi Y; Terasaki T; Yonehara T; Uchino M
    J Stroke Cerebrovasc Dis; 2013 May; 22(4):290-6. PubMed ID: 22000527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted MRI helps predict outcome in basilar artery occlusion patients treated with intra-arterial thrombolysis.
    Karameshev A; Arnold M; Schroth G; Kappeler L; Stein P; Gralla J; Brekenfeld C; Findling O; Mono ML; De Marchis GM; Fischer U; Mattle HP; Nedeltchev K; El-Koussy M
    Cerebrovasc Dis; 2011; 32(4):393-400. PubMed ID: 21986058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical diffusion mismatch better discriminates infarct growth than mean transit time-diffusion weighted imaging mismatch in patients with middle cerebral artery-M1 occlusion and limited infarct core.
    Nogueira RG; Kemmling A; Souza LM; Payabvash S; Hirsch JA; Yoo AJ; Lev MH
    J Neurointerv Surg; 2017 Feb; 9(2):127-130. PubMed ID: 26957483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.